Charles River Laboratories International, Inc.

Sümbol: CRL

NYSE

233.47

USD

Turuhind täna

25.2401
P/E suhe
2.6474
PEG suhe
11.99B
MRK Cap
0.00%
DIV tootlus

Charles River Laboratories International, Inc. (CRL) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Charles River Laboratories International, Inc. (CRL) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1511.744 M, mis on 0.134 % gowth. Kogu perioodi keskmine brutokasum on 560.185 M, mis on 0.134 %. Keskmine brutokasumi suhtarv on 0.375 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.024 %, mis on võrdne 0.093 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Charles River Laboratories International, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.078. Käibevara valdkonnas on CRL aruandlusvaluutas 1608.662. Märkimisväärne osa neist varadest, täpsemalt 276.771, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.183%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 243.811, kui neid on, aruandlusvaluutas. See näitab erinevust -21.756% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 3066.381 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.010%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 3596.882 aruandlusvaluutas. Selle aspekti aastane muutus on 0.209%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 780.375, varude hind on 380.26 ja firmaväärtus 3095.05, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 864.05. Kontovõlad ja lühiajalised võlad on vastavalt 168.94 ja 441.12. Koguvõlg on 3066.38, netovõlg on 2789.61. Muud lühiajalised kohustused moodustavad 203.21, mis lisandub kohustuste kogusummale 4536. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
balance-sheet.row.cash-and-short-term-investments	835.98	276.8	233.9	241.2	228.4	238	195.4	163.8	117.6	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	240.4	182.8	116.5	207.8	195.5	122.5	58.3	33.1	15	24.8
balance-sheet.row.short-term-investments	0	0	1	1.1	1	0.9	0.9	28.5	3.8	20.5	16.2	11.2	6.8	5.4	9.8	56.4	0	15	7.5	1.7	0.2	13.2	0	0	0	0	0
balance-sheet.row.net-receivables	3168.64	780.4	752.4	642.9	617.7	514	472.2	430	364.1	270.1	258	220.6	203	184.8	193	196.9	210.2	213.9	202.7	203.3	201.8	111.5	94.2	98.5	45.9	36.3	33.4
balance-sheet.row.inventory	1221.1	380.3	255.8	199.1	185.7	160.7	127.9	115	95.8	93.7	89	89.4	88.5	93	100.3	102.7	96.9	88	72.4	65.3	61.9	52.4	43.9	39.1	33.9	30.5	30.7
balance-sheet.row.other-current-assets	381.79	83.4	107.6	97.3	72.6	56	48.8	81.3	45	47.3	99.8	85.8	83.6	79.1	80.5	113.4	67.5	3.2	6.3	34.3	38.8	11.5	12.4	14.3	6.8	8.2	2.8
balance-sheet.row.total-current-assets	6006.12	1608.7	1439	1274.1	1201.1	1021.3	897.8	826.6	656.8	559.2	606.9	552.5	485.3	425.8	552.9	595.6	618.1	607.9	501.1	419.3	510.3	370.9	278.1	210.2	119.7	90.1	97.2
balance-sheet.row.property-plant-equipment-net	7763.95	2033.8	1857.4	1584	1302.6	1184.2	932.9	782	755.8	678	676.8	676.2	717	738	752.7	865.7	828.9	748.8	534.7	399.5	357.1	203.5	187.9	155.9	117	85.4	82.7
balance-sheet.row.goodwill	11797.87	3095	2849.9	2711.9	1809.2	1540.6	1247.1	804.9	787.5	438.8	321.1	230.7	208.6	197.6	198.4	508.2	457.6	1120.5	1119.3	1417.7	1422.6	0	96.5	52.1	41.9	0	0
balance-sheet.row.intangible-assets	3638.35	864.1	955.3	1061.2	787.6	689.4	610.9	369.8	394.4	280.8	178.9	84.5	84.9	93.4	121.2	160.3	136.1	148.9	160.2	1616.8	1678.9	135.7	130.7	90.4	41.9	37	0
balance-sheet.row.goodwill-and-intangible-assets	15436.21	3959.1	3805.2	3773.1	2596.8	2230	1858	1174.7	1182	719.6	500	315.2	293.5	291	319.7	668.5	593.7	1269.4	1279.5	1616.8	1678.9	135.7	130.7	90.4	41.9	37	17.7
balance-sheet.row.long-term-investments	1139.73	243.8	311.6	201.4	221.8	123	88.6	71.1	45.3	32.7	27	17.9	8.5	0	0	0	0	0	0	0	0	0	0	3	2.4	0	18.5
balance-sheet.row.tax-assets	154.1	40.3	41.3	40.2	37.7	44.7	23.4	22.7	28.7	40	23.2	35.5	38.6	44.8	45	19	62.9	89.3	107.5	67.9	50.4	61.6	80.9	8.7	-2.4	0	5.8
balance-sheet.row.other-non-current-assets	773.71	309.4	148.3	151.5	130.8	89.6	55.2	52.9	43.1	38.9	51.3	47.2	43.5	58.6	63.1	55.2	56.2	90.2	134.7	34.7	30.1	27.9	23.8	103.2	132	150.6	12.4
balance-sheet.row.total-non-current-assets	25267.71	6586.3	6163.7	5750.2	4289.7	3671.5	2958	2103.3	2055	1509.3	1278.3	1092.1	1101.1	1132.5	1180.5	1608.5	1541.8	2197.7	2056.5	2118.9	2116.5	428.7	423.3	361.2	290.9	273	137
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	31273.83	8195	7602.8	7024.3	5490.8	4692.8	3855.9	2929.9	2711.8	2068.5	1885.2	1644.6	1586.3	1558.3	1733.4	2204.1	2159.9	2805.5	2557.5	2538.2	2626.8	799.6	701.3	571.4	410.6	363.1	234.3
balance-sheet.row.account-payables	565.49	168.9	205.9	198.1	122.5	111.5	66.3	77.8	68.5	36.7	33.8	31.8	31.2	34.3	30.6	31.2	40.5	36.7	28.2	30.4	28.7	19.4	13.1	13.9	10.8	9.3	11.6
balance-sheet.row.short-term-debt	1281.68	441.1	50.2	2.8	50.2	38.5	31.4	31	27.3	17	31.9	21.4	139.4	14.8	30.6	35.4	35.5	25.1	25	36.4	80.9	61	67.2	0.9	0.4	3.5	0.4
balance-sheet.row.tax-payables	166.91	38.8	39.9	26.2	24.9	26.1	24.1	43.3	25.6	12.2	9.4	18.8	18.2	10.6	0	0	0	0	0	0	0	0	7	4	0	0	14.3
balance-sheet.row.long-term-debt-total	12213.11	3066.4	3097.3	2916.5	2085.2	1965.9	1636.6	1114.1	1207.7	846	746	642.4	527.1	703.2	670.3	457.4	540.6	485	547.1	260.2	606	185.7	192.5	155.9	202.5	382.5	1.2
Deferred Revenue Non Current	119.13	30.9	25.8	20.6	19.5	21	34.4	3.9	5.8	7.9	-22.5	-6.9	-4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	796.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1178.82	203.2	571.2	612.6	459.1	388.3	315.4	237.1	206.1	176.7	152.3	139.7	115.2	111.2	131.7	110.7	138.3	138.7	112.9	128.2	122.1	3.1	6	61.5	53.1	56.9	11.2
balance-sheet.row.total-non-current-liabilities	13769.39	3480.9	3487.7	3399.1	2507.4	2316.1	1959.4	1402.4	1428.4	991.2	884.7	732.9	640.9	812.4	784.9	580.5	659.5	639	693.8	390.1	795.4	210.4	212	170.3	216	403.2	3.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1629.5	419.2	389.7	253	155.6	116.3	26.1	27.9	27.2	31.8	24.1	0.7	0	703.2	0	0	0	0	0	0	0	0	0.1	0.4	0	0	1.1
balance-sheet.row.total-liab	17807.3	4536	4579.3	4432.3	3347.2	3026.3	2517.6	1865.9	1858	1302.9	1180.8	980	983.1	1029.2	1044.6	830.3	960.5	941.6	953.1	701.5	1144.5	324.8	325.4	268.9	280.4	472.9	65.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2.05	0.5	0.5	0.5	0.5	0.5	0.5	0.9	0.9	0.9	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.7	0.7	0.7	0.5	0.5	0.4	0.4	0.1	0
balance-sheet.row.retained-earnings	6776.74	1887.2	1432.9	980.8	625.4	280.3	42.1	288.7	165.3	10.5	-138.8	-265.5	-368.3	-465.6	-575.2	-238.5	-344.3	177.5	23.1	78.9	-63.1	-152.9	-233	-283.2	-318.6	-307.4	156.1
balance-sheet.row.accumulated-other-comprehensive-income-loss	-911.89	-196.4	-262.1	-164.7	-138.9	-178	-172.7	-144.7	-253.8	-135.5	-74.2	5.4	6.6	4.6	33.6	45	3.3	85.6	21.2	-12.2	16.1	7.3	-11.8	-16.7	-16.3	-9.9	-5.7
balance-sheet.row.other-total-stockholders-equity	7396.27	1905.6	1804.9	1718.3	1627.6	1531.8	1447.5	900.3	924.4	857.2	884.4	900.3	961.7	987.6	1228.2	1566.5	1539.2	1596.6	1550.2	1759.6	1518.9	609.8	601.7	588.9	451.4	207	17.8
balance-sheet.row.total-stockholders-equity	13263.17	3596.9	2976.3	2534.8	2114.6	1634.6	1317.3	1045.1	836.8	733.1	672.2	641	600.8	527.4	687.4	1373.8	1199	1860.5	1595.2	1827	1472.5	464.6	357.4	289.5	116.9	-110.1	168.3
balance-sheet.row.total-liabilities-and-stockholders-equity	31273.83	8195	7602.8	7024.3	5490.8	4692.8	3855.9	2929.9	2711.8	2068.5	1885.2	1644.6	1586.3	1558.3	1733.4	2204.1	2159.9	2805.5	2557.5	2538.2	2626.8	799.6	701.3	571.4	410.6	363.1	234.3
balance-sheet.row.minority-interest	203.35	62.1	47.2	57.2	29.1	31.9	21	18.9	17	32.5	32.1	23.7	2.4	1.8	1.3	-1.4	0.4	3.5	9.2	9.7	9.8	10.2	18.6	13	13.3	0.3	0.3
balance-sheet.row.total-equity	13466.53	3659	3023.5	2592	2143.7	1666.5	1338.3	1064	853.8	765.6	704.3	664.7	603.2	529.1	688.7	1372.4	1199.4	1864	1604.4	1836.7	1482.3	474.8	375.9	302.5	130.3	-109.8	168.6
balance-sheet.row.total-liabilities-and-total-equity	31273.83	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	1139.73	243.8	311.6	202.4	222.8	123.9	89.5	99.6	49.1	53.2	43.2	29.1	15.3	5.4	9.8	56.4	0	15	7.5	1.7	0.2	13.2	0	3	2.4	0	18.5
balance-sheet.row.total-debt	12213.11	3066.4	3097.3	2919.3	2135.4	2004.5	1668	1145.1	1235	863	777.9	663.8	666.5	717.9	700.9	492.8	576.1	510	572.1	296.7	686.8	185.7	192.5	156.8	202.9	386	1.6
balance-sheet.row.net-debt	11377.13	2789.6	2863.4	2678.1	1907	1766.4	1472.6	981.3	1117.4	745.1	617.8	507.9	556.8	649	521.7	310.3	332.5	284.6	396.7	181.8	479.3	3.4	70	98.5	169.8	371	-23.2

Rahavoogude aruanne

Charles River Laboratories International, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.239 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 25.6, mis tähistab 0.786 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -563155000.000. See on -0.074 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 314.12, -2.29, -851.68, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -25.6 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 790.31, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	480.37	480.4	492.6	398.8	365.3	254.1	227.2	125.6	156.1	152	129.9	105.4	102.1	115.5	-334.1	109.4	-522.3	154.4	-55.8	142	89.8	80.2	50.1	35.4	17.9	17.1	23.4
cash-flows.row.depreciation-and-amortization	314.12	314.1	303.9	265.5	234.9	198.1	161.8	131.2	126.7	94.9	96.4	96.6	81.3	85.2	93.6	93.6	91.2	88.9	85.1	104.6	48.2	31.1	25.7	28.6	18.9	15.6	10.9
cash-flows.row.deferred-income-tax	-50.9	-50.9	-35.9	-24	-0.1	-21.9	-9.7	28.3	1.9	2.7	7.1	-0.8	1.3	-8.7	-42.3	15.8	12.7	-9.8	4	-37.4	9.1	8.9	11.3	17.2	-0.9	8.6	-3.1
cash-flows.row.stock-based-compensation	72.05	72	73.6	71.5	56.3	57.3	47.3	44	43.6	40.1	31	24.5	21.9	21.7	25.5	23.8	24.3	21.1	21.1	17	3.8	0	1	4.5	8.2	0	0
cash-flows.row.change-in-working-capital	-102.38	-102.4	-152.6	42.9	-26.3	6.2	14.8	5.9	-30	9.6	-3.8	-25.4	-26	-27	7.6	-43.4	-32.2	19.2	-58.6	-10.5	12.2	-4.9	16.7	-20.9	-9.3	-2.9	7.4
cash-flows.row.account-receivables	-33.43	-33.4	-150.6	-26.6	-85.6	-8.3	-21.2	-48.3	-52.8	-17	-28.1	-19.5	-16.3	7.7	-5.6	21.8	-8.5	-19	-19	-9.5	-7.3	0	11.7	-27.5	0	0	0
cash-flows.row.inventory	-62.3	-62.3	-78.5	-25.2	-18.4	-21.4	-13.3	-17.8	-4	3.4	-3	-1.6	0.8	3.8	2	-4.4	-9.7	-13	-6.5	-5.8	-6.4	-5.7	-1.6	-3.8	-2.3	0.1	-1.3
cash-flows.row.account-payables	-20.43	-20.4	-2.7	44.9	0.7	29.8	-12.7	0	22.1	1.2	4.6	-7.1	-3.3	2.2	0.1	-11.5	8.2	-2.6	-2.6	2.5	-2.3	0	-3.8	0.3	0	0	0
cash-flows.row.other-working-capital	13.78	13.8	79.2	49.8	77	6.1	62.1	72	4.7	22	22.7	2.8	-7.3	-40.7	11.1	-49.3	-22.2	53.7	-30.6	2.2	28.1	0.9	10.3	10	-7	-3.1	8.6
cash-flows.row.other-non-cash-items	-29.36	-29.4	-62	6	-83.6	-12.8	-0.3	-18.7	0	-13	-9.6	6.7	27.4	18.5	418.7	25.9	706.2	10.4	168.5	21	21.8	8.5	28.9	6.6	-1	-0.9	-1.2
cash-flows.row.net-cash-provided-by-operating-activities	683.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-318.53	-318.5	-324.7	-228.8	-166.6	-140.5	-140.1	-82.4	-55.3	-63.3	-56.9	-39.2	-47.5	-49.1	-42.9	-80	-197.1	-227	-181.7	-95.5	-45.3	-32.7	-37.5	-36.7	-15.6	-13	-11.9
cash-flows.row.acquisitions-net	-203.71	-194.8	-120.1	-1170.4	-418.6	-515.7	-824.9	47.5	-648.5	-247.7	-234.3	-29.2	-16.9	0	2.8	-83.3	-69.2	-11.6	-30.9	-3.4	-572	-10.8	-42.5	-55.3	-6	-23.1	-11.8
cash-flows.row.purchases-of-investments	-54.22	-54.2	-158.3	-45.6	-26.7	-22.3	-25.1	-46.2	-40.2	-34.2	-26.6	-17.6	-18.5	-24.6	-27.6	-102.3	-6.4	-299.4	-207.9	-15.6	-16.7	-21.8	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	6.67	6.7	4.5	6.5	11.4	0.9	35.8	9.1	54	27.1	21	11.6	25.2	31.6	72.5	52.8	45.4	334.5	123	0.4	32.6	1.1	0	0	0	0	0
cash-flows.row.other-investing-activites	6.63	-2.3	-9.3	0.3	-1.1	-3.9	-0.8	-0.5	3.7	-2.2	-1.1	0.3	2.8	5.4	0.9	4	0.1	2.7	189.5	0.1	1.4	0.9	1.2	0	7	1.8	0.7
cash-flows.row.net-cash-used-for-investing-activites	-563.15	-563.2	-607.9	-1437.9	-601.5	-681.5	-955	-72.6	-686.4	-320.3	-298	-74	-55	-36.6	5.8	-208.8	-227.2	-200.8	-108	-114	-600	-63.4	-78.9	-91.9	-14.6	-34.2	-23
cash-flows.row.debt-repayment	-851.68	-851.7	-2932.6	-6242.9	-2200.4	-3124.6	-2201	-372.4	-656.6	-417.3	-194.5	-523.3	-140.3	-253	-381.5	-54.1	-36.5	-62.6	-271.2	-203.8	0	0	0	0	0	0	-1.3
cash-flows.row.common-stock-issued	25.6	25.6	25.1	45.7	46.6	34.5	0	0	0	0	0	0	0	0	0	0	0	54	88.3	27.1	26.6	4	5.3	116.7	236	103	0
cash-flows.row.common-stock-repurchased	-24.16	-24.2	-38.7	-40.7	-24	-18.1	-13.8	-106.9	-12.3	-117.5	-122	-165.9	-64.2	-283.8	-356.5	-45.9	-115.1	-41.6	-250	-18	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-25.6	0	-45.7	-46.6	-34.5	0	0	0	0	0	0	0	0	0	0	0	-1.9	-1.9	-1.4	-2.1	-1.9	-1.5	-0.7	0	0	0
cash-flows.row.other-financing-activites	778.52	790.3	2903.8	6956.2	2271.6	3374.6	2772.9	270.9	1059.6	539.4	378	605	93.4	265	570.2	19.1	134.3	5.8	440.1	-1.5	412.5	-10.9	1.4	-68.7	-235.2	-114.5	-6.7
cash-flows.row.net-cash-used-provided-by-financing-activities	-85.52	-85.5	-42.4	672.6	47.2	231.9	558.1	-208.5	390.7	4.5	61.4	-84.2	-111.1	-271.8	-167.9	-81	-17.3	-46.4	5.4	-197.6	436.9	-8.8	5.2	47.2	0.8	-11.5	-8
cash-flows.row.effect-of-forex-changes-on-cash	8.04	8	25.6	17.7	0.8	11.4	-9.5	11.2	-3	-12.7	-10.4	-2.6	-1	-7.1	-10.3	3.7	-17.3	13	-1.2	-17.9	3.4	8.2	4.3	-1.5	-1.9	-1.7	0.6
cash-flows.row.net-change-in-cash	43.27	43.3	-5.1	13.2	-6.9	42.7	31	46.4	-0.3	-42.1	4.1	46.2	40.8	-110.3	-3.4	-61	18.1	50.1	60.6	-92.7	25.2	59.8	64.2	25.1	18.1	-9.8	6.9
cash-flows.row.cash-at-end-of-period	867.76	284.5	241.2	246.3	233.1	240	197.3	166.3	117.6	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	225.4	175.4	114.8	207.6	182.3	122.5	58.3	33.1	15	24.8
cash-flows.row.cash-at-beginning-of-period	824.5	241.2	246.3	233.1	240	197.3	166.3	119.9	117.9	160	155.9	109.7	68.9	179.2	182.6	243.6	225.4	175.4	114.8	207.6	182.3	122.5	58.3	33.1	15	24.8	17.9
cash-flows.row.operating-cash-flow	683.9	683.9	619.6	760.8	546.6	480.9	441.1	316.3	298.3	286.4	251.1	207.1	207.9	205.3	169	225	279.9	284.2	164.4	236.7	184.8	123.8	133.7	71.3	33.8	37.6	37.4
cash-flows.row.capital-expenditure	-318.53	-318.5	-324.7	-228.8	-166.6	-140.5	-140.1	-82.4	-55.3	-63.3	-56.9	-39.2	-47.5	-49.1	-42.9	-80	-197.1	-227	-181.7	-95.5	-45.3	-32.7	-37.5	-36.7	-15.6	-13	-11.9
cash-flows.row.free-cash-flow	365.37	365.4	294.9	532	380	340.4	301.1	233.8	243	223.1	194.1	168	160.4	156.1	126.2	145	82.9	57.2	-17.4	141.2	139.5	91.1	96.1	34.6	18.2	24.6	25.5

Kasumiaruande rida

Charles River Laboratories International, Inc. tulud muutusid võrreldes eelmise perioodiga 0.039%. CRL brutokasum on teatatud 1502.56. Ettevõtte tegevuskulud on 885.29, mille muutus võrreldes eelmise aastaga on 9.070%. Kulud amortisatsioonikulud on 314.12, mis on -0.063% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 885.29, mis näitab 9.070% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.052% kasvu võrreldes eelmise aastaga. Tegevustulu on 617.26, mis näitab -0.052% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.024%. Eelmise aasta puhaskasum oli 474.62.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
income-statement-row.row.total-revenue	4129.41	4129.4	3976.1	3540.2	2923.9	2621.2	2266.1	1857.6	1681.4	1363.3	1297.7	1165.5	1129.5	1142.6	1133.4	1202.6	1343.5	1230.6	1058.4	1122.2	766.9	613.7	554.6	465.6	306.6	219.3	193.3
income-statement-row.row.cost-of-revenue	2626.85	2626.9	2513.4	2205.5	1850.4	1662.9	1426	1155.3	1034.8	832.2	825	770.6	737.4	740.4	748.7	773.2	832.8	752.4	651.8	693.5	468.4	380.1	345.6	298.4	171.4	120.9	122.5
income-statement-row.row.gross-profit	1502.56	1502.6	1462.7	1334.6	1073.5	958.3	840.1	702.3	646.7	531.1	472.7	394.9	392.1	402.2	384.8	429.4	510.7	478.2	406.6	428.7	298.6	233.7	209	167.3	135.1	98.4	70.8
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	133.73	95.5	146.6	124.9	111.9	89.5	13.3	38.5	11.9	3	10.7	7.2	-3.3	21.8	24.4	28.4	30.3	33.5	37.6	58.2	16.8	4.9	3.4	8.7	18.9	15.6	1.3
income-statement-row.row.operating-expenses	885.29	885.3	811.7	744.8	640.8	607.2	508.7	414.8	409.2	324.6	295	243.5	226.3	227.9	286.9	262.4	260.5	251	218.4	247.7	138.2	95.1	86.7	77	70.1	55.4	35.4
income-statement-row.row.cost-and-expenses	3512.15	3512.1	3325.1	2950.3	2491.2	2270.1	1934.7	1570.1	1444	1156.9	1120	1014.1	963.8	968.3	1035.5	1035.6	1093.3	1003.4	870.2	941.2	606.6	475.2	432.4	375.3	241.5	176.3	158
income-statement-row.row.interest-income	5.2	5.2	0.8	0.7	0.8	1.5	0.8	0.7	1.3	1	1.2	0.7	0.6	1.4	1.2	1.8	8.7	9.7	6.8	3.9	3.3	0	2.1	1.5	0	0	0
income-statement-row.row.interest-expense	136.71	136.7	59.3	73.9	86.4	60.9	63.8	29.8	27.7	15.1	11.9	21	33.3	41.2	34.1	21.7	14	14.8	193.2	22.6	8.7	6.6	27.3	27.3	67.4	8.3	-2.1
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	61.96	95.5	-28	-109.2	14.4	-47.1	13.3	38.5	11.9	3	10.7	7.2	-3.3	-0.4	-397.9	2.1	-705.9	-1.4	1	-0.2	0.7	0.8	1.5	1	1.1	2	-0.1
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	133.73	95.5	146.6	124.9	111.9	89.5	13.3	38.5	11.9	3	10.7	7.2	-3.3	21.8	24.4	28.4	30.3	33.5	37.6	58.2	16.8	4.9	3.4	8.7	18.9	15.6	1.3
income-statement-row.row.total-operating-expenses	61.96	95.5	-28	-109.2	14.4	-47.1	13.3	38.5	11.9	3	10.7	7.2	-3.3	-0.4	-397.9	2.1	-705.9	-1.4	1	-0.2	0.7	0.8	1.5	1	1.1	2	-0.1
income-statement-row.row.interest-expense	136.71	136.7	59.3	73.9	86.4	60.9	63.8	29.8	27.7	15.1	11.9	21	33.3	41.2	34.1	21.7	14	14.8	193.2	22.6	8.7	6.6	27.3	27.3	67.4	8.3	-2.1
income-statement-row.row.depreciation-and-amortization	311.65	314.1	335.2	230.3	335.7	211.9	64.8	41.4	41.7	24.2	26	17.8	18.1	21.8	24.4	28.4	30.3	88.9	85.1	104.6	48.2	31.1	25.7	28.6	18.9	15.6	10.9
income-statement-row.row.ebitda-caps	1032.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	617.26	617.3	651	589.9	432.7	351.2	331.4	287.5	237.4	206.4	177.7	151.4	165.8	174.3	-298.5	166.9	-449.8	227.2	188.2	181	160.3	138.6	122.3	90.3	65.1	43	35.3
income-statement-row.row.income-before-tax	581.28	581.3	623	480.7	447.1	304.1	281.7	297	222.9	195.4	177.6	138.3	129.7	132.7	-334.1	149.1	-461	217.4	176.6	160.4	152.5	132.6	114.4	69.5	25.7	32.7	35.8
income-statement-row.row.income-tax-expense	100.91	100.9	130.4	81.9	81.8	50	54.5	171.4	66.8	43.4	47.7	32.9	27.6	17.1	0	39.7	61.9	59.4	49.7	16.6	61.2	51.1	43.6	27.1	7.8	15.6	14.1
income-statement-row.row.net-income	474.62	474.6	486.2	391	364.3	252	226.4	123.4	154.8	149.3	126.7	102.8	97.3	109.6	-336.7	114.4	-521.8	154.4	-55.8	142	89.8	80.2	50.1	35.4	-11.2	17.1	23.4